Skip to main content

Alaunos Therapeutics, Inc.

TCRT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001107421

No open-market purchases or sales by Alaunos Therapeutics, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $204.4K in total; no superinvestor holds it.

13F holders, Q2 2026

Institutional positions in Alaunos Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
29
+2 vs. Q1 2026
Shares held
90.4K
−35.5K (−28.2%) vs. Q1 2026
Total value
$204.4K
−$156.1K (−43.3%) vs. Q1 2026
New holders
6
6 more added
Sold out
4
3 more reduced

2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TCRT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 29 institutions
Q1 2021: 153 institutionsQ2 2021: 156 institutionsQ3 2021: 163 institutionsQ4 2021: 167 institutionsQ1 2022: 149 institutionsQ2 2022: 125 institutionsQ3 2022: 125 institutionsQ4 2022: 124 institutionsQ1 2023: 110 institutionsQ2 2023: 102 institutionsQ3 2023: 92 institutionsQ4 2023: 86 institutionsQ1 2024: 46 institutionsQ2 2024: 50 institutionsQ3 2024: 29 institutionsQ4 2024: 30 institutionsQ1 2025: 29 institutionsQ2 2025: 28 institutionsQ3 2025: 26 institutionsQ4 2025: 27 institutionsQ1 2026: 29 institutionsQ2 2026: 29 institutions
Value heldQ2 2026: $204.4K
Q1 2021: $422.7MQ2 2021: $297.6MQ3 2021: $194.1MQ4 2021: $155.9MQ1 2022: $65.8MQ2 2022: $90.7MQ3 2022: $128.6MQ4 2022: $50.5MQ1 2023: $44.7MQ2 2023: $34.2MQ3 2023: $7.36MQ4 2023: $2.96MQ1 2024: $4.23MQ2 2024: $1.69MQ3 2024: $622.8KQ4 2024: $137.0KQ1 2025: $103.4KQ2 2025: $344.6KQ3 2025: $158.3KQ4 2025: $349.9KQ1 2026: $360.5KQ2 2026: $204.4K
Institutions holding TCRT and their total value by quarter
QuarterHoldersValue
Q2 202629$204.4K
Q1 202629$360.5K
Q4 202527$349.9K
Q3 202526$158.3K
Q2 202528$344.6K
Q1 202529$103.4K
Q4 202430$137.0K
Q3 202429$622.8K
Q2 202450$1.69M
Q1 202446$4.23M
Q4 202386$2.96M
Q3 202392$7.36M
Q2 2023102$34.2M
Q1 2023110$44.7M
Q4 2022124$50.5M
Q3 2022125$128.6M
Q2 2022125$90.7M
Q1 2022149$65.8M
Q4 2021167$155.9M
Q3 2021163$194.1M
Q2 2021156$297.6M
Q1 2021153$422.7M

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Alaunos Therapeutics, Inc.; share changes are against Q1 2026.

Institutions holding TCRT in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.21,353$48.3K0.00%00.0%Unchanged
Geode Capital Management, LLC19,356$43.8K0.00%−3,204−14.2%Reduced
Vanguard Fiduciary Trust Co15,497$35.0K0.00%00.0%Unchanged
Vanguard Capital Management LLC14,063$31.8K0.00%00.0%Unchanged
Citadel Advisors LLC11,870$26.8K0.00%+1,351+12.8%Added
Advisor Group Holdings, Inc.1,731$3.91K0.00%−48−2.7%Reduced
Tower Research Capital LLC (TRC)1,621$3.66K0.00%+38+2.4%Added
SRS Capital Advisors, Inc.1,216$2.75K0.00%+1,216New
UBS Group AG992$2.24K0.00%−1,282−56.4%Reduced
Morgan Stanley836$1.89K0.00%+183+28.0%Added
Vanguard Global Advisers, LLC501$1.13K0.00%00.0%Unchanged
Royal Bank of Canada375$1.00K0.00%+190+102.7%Added
Wells Fargo & Company388$8770.00%+198+104.2%Added
Ronald Blue Trust, Inc.135$3050.00%00.0%Unchanged
Steward Partners Investment Advisory, LLC112$2530.00%+20+21.7%Added
Federation des caisses Desjardins du Quebec70$1580.00%00.0%Unchanged
Bokf, NA66$1490.00%+66New
Axiom Investment Management LLC46$1040.00%+46New
Key Financial Inc24$540.00%00.0%Unchanged
Signaturefd, LLC23$520.00%00.0%Unchanged
Newbridge Financial Services Group, Inc.21$470.00%00.0%Unchanged
NBC Securities, Inc.20$450.00%00.0%Unchanged
AdvisorNet Financial, Inc19$430.00%00.0%Unchanged
Barclays PLC15$340.00%+15New
West Paces Advisors Inc.10$230.00%+10New
CWM Advisors, LLC9$200.00%00.0%Unchanged
BNP Paribas Arbitrage, SA6$140.00%00.0%Unchanged
IFG Advisory, LLC6$140.00%+6New
Tidemark, LLC2$50.00%00.0%Unchanged
HRT Financial LP0$00.00%−13,327−100.0%Sold out
Two Sigma Investments, LP0$00.00%−10,839−100.0%Sold out
XTX Topco Ltd0$00.00%−10,174−100.0%Sold out
Citigroup Inc0$00.00%−1−100.0%Sold out
Sunbelt Securities, Inc.––––Not filed
CWM, LLC––––Not filed